Skip to main content
. 2022 May 17;13:888660. doi: 10.3389/fphar.2022.888660

FIGURE 6.

FIGURE 6

Relationship between plasma peak rivaroxaban level and (A) prothrombin time (PT) and (B) activated partial thromboplastin time (APTT).